Sára Tóth - Concepedia

Author

Sára Tóth

Also Known As

S Toth, S Tóth, S W Toth, S. Toth, S. Tóth, Sara Toth, Sara Toth, APRN, FNP-C, AOCNP, AGN-BC, Sara Toth, FNP-C, AOCNP, AGN-BC, Sara Tóth, Sára Tóth

102

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Semmelweis University Hungarian Academy of Sciences Heim Pál Országos Gyermekgyógyászati Intézet HUN-REN Institute of Experimental Medicine Budapest University of Technology and Economics

About

Sára Tóth is an author at Semmelweis University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	22	937
2	Health Sciences	1	1	14
3	Natural Sciences	1	1	14
4	Nursing	1	1	59
5	Public Health	1	1	59

Sára Tóth

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage Peter D. Rathjen, Sára Tóth, Anthony C. Willis, Cell Systems BiologyDevelopmental BiologyProtein ExpressionMedicineGene Regulation	1990	271
Antibiotic-induced release of small extracellular vesicles (exosomes) with surface-associated DNA Andrea H. Németh, Norbert Orgován, Barbara W. Sódar, Scientific Reports	2017	147
TIM-3 Is Expressed in Melanoma Cells and Is Upregulated in TGF-Beta Stimulated Mast Cells Zoltán Wiener, Barbara Kőhalmi, Péter Pócza, Journal of Investigative Dermatology MedicineMast Cell DisorderMelanomaImmunologyMelanoma Cells	2006	134
Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Peter D. Rathjen, Jennifer Nichols, Sára Tóth, Genes & Development	1990	125
IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice Zoltán Wiener, András Falus, Sára Tóth Cytokine InflammationCytokineImmune Cell DevelopmentMedicineMast Cell Disorder	2004	71
Telemedicine in Community Cancer Care: How Technology Helps Patients With Cancer Navigate a Pandemic Debra A. Patt, Lalan S. Wilfong, Sára Tóth, JCO Oncology Practice Family MedicineRemote Patient MonitoringRural AreasTelemedicine PlatformPrimary Care	2021	59
Critical role of extracellular vesicles in modulating the cellular effects of cytokines Tamás Szabó, Bettina Tarr, Krisztina Pálóczi, Cellular and Molecular Life Sciences InflammationExtracellular VesiclesCytokineCritical RoleCell Trafficking	2014	47
Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin‐6 Eszter Lázár‐Molnár, Hargita Hegyesi, Éva Pállinger, European Journal of Clinical Investigation	2002	43
Lymphocytes from rheumatoid arthritis patients have elevated levels of intracellular peroxiredoxin 2, and a greater frequency of cells with exofacial peroxiredoxin 2, compared with healthy human lymphocytes Katalin Szabó-Taylor, Paul Eggleton, Carly A.L. Turner, The International Journal of Biochemistry & Cell Biology ImmunologyImmune RegulationPathologyPeroxiredoxin 2Oxidative Stress	2012	42
Phenotypic Profiling of Engineered Mouse Melanomas with Manipulated Histamine Production Identifies Histamine H2 Receptor and Rho-C as Histamine-Regulated Melanoma Progression Markers Zoltán Pós, Géza Sáfrány, Kerstin Müller, Cancer Research	2005	33

Page 1